ResultsIQ

ResultsIQ › Latest results › Meghmani Organics Limited

Meghmani Organics Limited Q3 FY26 results deck summary

NSE: MOL · BSE: 543331

Results deck of 31 Jan 2026, summarised by AI from the filing.

Q3 FY26 standalone revenue ₹484.9 cr, down 13% YoY, on softer demand from US trade policy uncertainty.

Key takeaways

  1. Revenue Standalone revenue from operations ₹484.9 cr in Q3 FY26, down 13% YoY.
  2. Guidance Capex program to bring blended EBITDA margin of ~14-15%.
  3. Driver New-age insecticide products from the 5,000 MTPA Dahej MPP plant and Nano Urea plant.
  4. Risk Softer demand due to US trade policy uncertainty pressured export volumes and profitability.

Original filing on BSE

Meghmani Organics Limited Q1 FY27 results

As filed: Revenue ₹543 cr (−12% year on year), EBITDA ₹97.9 cr (+48% year on year), PAT ₹48.2 cr (+271% year on year), EBITDA margin 18.0% (+729 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹474 cr (−14% year on year), EBITDA ₹19.7 cr (−70% year on year), PAT ₹8.0 cr (−60% year on year), EBITDA margin 4.2% (−760 bps). Score 11 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 760 bps year on year. Other income 521% of PBT. Tax rate -12%. Revenue fell 7% from last quarter. Share price after the results: −10.4% in 30 days (Nifty 500: +1.3%).
  • Q3 FY26: Revenue ₹509 cr (−11% year on year), EBITDA ₹37.7 cr (−8% year on year), PAT −₹3.5 cr, EBITDA margin 7.4% (+21 bps). Score 23 of 100, Below trend. Revenue and EBITDA growth were below the company's own trend. EBITDA margin rose 21 bps year on year. Other income 329% of PBT. Tax rate 178%. Revenue fell 12% from last quarter. Share price after the results: −9.3% in 30 days (Nifty 500: −1.1%).
  • Q2 FY26: Revenue ₹577 cr (+6% year on year), EBITDA ₹52.0 cr (+73% year on year), PAT ₹12.0 cr, EBITDA margin 9.0% (+350 bps). Score 35 of 100, Below trend. Revenue and EBITDA growth were in line with the company's own trend. EBITDA margin rose 350 bps year on year. Other income 108% of PBT. Tax rate 54%. Revenue fell 6% from last quarter. Share price after the results: −15.2% in 30 days (Nifty 500: 0.0%).
  • Q1 FY26: Revenue ₹614 cr (+48% year on year), EBITDA ₹66.0 cr (+300% year on year), PAT ₹13.0 cr, EBITDA margin 10.8% (+930 bps). Score 59 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend. EBITDA margin rose 930 bps year on year. Other income 71% of PBT. Tax rate 46%. Profit fell 35% from last quarter. Share price after the results: −11.0% in 28 days (Nifty 500: −1.3%).
  • Q4 FY25: Revenue ₹553 cr (+35% year on year), EBITDA ₹65.0 cr (+300% year on year), PAT ₹20.0 cr, EBITDA margin 11.8% (+1,000 bps). Score 56 of 100, In line with trend. Revenue growth was above the company's own trend. EBITDA margin rose 1000 bps year on year. Other income 45% of PBT. Tax rate 35%. Share price after the results: +29.6% in 30 days (Nifty 500: +7.6%).
  • Q3 FY25: Revenue ₹569 cr (+62% year on year), EBITDA ₹41.0 cr, PAT −₹4.0 cr, EBITDA margin 7.2% (+948 bps). Score 45 of 100, In line with trend. Revenue growth was well above the company's own trend. EBITDA margin rose 948 bps year on year. Other income 129% of PBT. Tax rate 171%.
  • Q2 FY25: Revenue ₹544 cr (+44% year on year), EBITDA ₹30.0 cr (+275% year on year), PAT −₹9.0 cr, EBITDA margin 5.5% (+340 bps). Score 45 of 100, In line with trend. EBITDA margin rose 340 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Meghmani Organics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.